Search Results - "JEPPESEN, P. B"
-
1
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
Published in Gut (01-07-2011)“…Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric…”
Get more information
Journal Article -
2
Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells
Published in Diabetes, obesity & metabolism (01-07-2014)“…Aims Caffeic acid, naringenin and quercetin are naturally occurring phenolic compounds (PCs) present in many plants as secondary metabolites. The aim of this…”
Get full text
Journal Article -
3
Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide – Analyses from a randomised, placebo-controlled study
Published in Clinical nutrition (Edinburgh, Scotland) (01-10-2013)“…Summary Background & aims Short bowel syndrome (SBS)-intestinal failure (IF) patients have impaired quality of life (QoL) and suffer from the burden of…”
Get full text
Journal Article -
4
European Society of Coloproctology consensus on the surgical management of intestinal failure in adults
Published in Colorectal disease (01-06-2016)“…Intestinal failure (IF) is a debilitating condition of inadequate nutrition due to an anatomical and/or physiological deficit of the intestine. Surgical…”
Get full text
Journal Article -
5
Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale
Published in Clinical nutrition (Edinburgh, Scotland) (01-10-2013)“…Summary Background & aims Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to…”
Get full text
Journal Article -
6
Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients
Published in Gut (01-09-2005)“…Background and aims: Glucagon-like peptide 2 (GLP-2) may improve intestinal absorption in short bowel syndrome (SBS) patients with an end jejunostomy…”
Get full text
Journal Article -
7
Increased Insulin Sensitivity and Changes in the Expression Profile of Key Insulin Regulatory Genes and Beta Cell Transcription Factors in Diabetic KKAy-Mice after Feeding with a Soy Bean Protein Rich Diet High in Isoflavone Content
Published in Journal of agricultural and food chemistry (25-06-2008)“…High content isoflavone soy protein (SBP) (Abalon) has been found in animal studies to possess beneficial effects on a number of the characteristic features of…”
Get full text
Journal Article -
8
Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat
Published in Metabolism, clinical and experimental (01-03-2003)“…Stevioside, a glycoside present in the leaves of the plant, Stevia rebaudiana Bertoni (SrB), has acute insulinotropic effects in vitro. Its potential…”
Get full text
Journal Article -
9
Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome
Published in European journal of clinical nutrition (01-09-2012)“…Background/Objectives: Colostrum is rich in immunoregulatory, antimicrobial and trophic components supporting intestinal development and function in newborns…”
Get full text
Journal Article -
10
Stevioside acts directly on pancreatic β cells to secrete insulin : Actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity
Published in Metabolism, clinical and experimental (01-02-2000)“…The natural sweetener stevioside, which is found in the plant Stevia rebaudiana Bertoni, has been used for many years in the treatment of diabetes among…”
Get full text
Journal Article -
11
Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study
Published in Gut (01-08-2000)“…BACKGROUND High dose growth hormone, glutamine, and a high carbohydrate diet may improve intestinal function in short bowel patients. AIMS To investigate if…”
Get full text
Journal Article -
12
Quality of life in patients receiving home parenteral nutrition
Published in Gut (01-06-1999)“…BACKGROUND/AIMS Quality of life is an important determinant of the effectiveness of health technologies, but it has rarely been assessed in patients receiving…”
Get full text
Journal Article -
13
Intestinal failure defined by measurements of intestinal energy and wet weight absorption
Published in Gut (01-05-2000)“…BACKGROUND AND AIMS Intestinal failure defined by the minimal energy and wet weight absorption required to avoid home parenteral nutrition (HPN) is not well…”
Get full text
Journal Article -
14
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon
Published in Gut (01-09-2000)“…BACKGROUND The glucagon-like peptides (GLP) 1 and 2 are secreted postprandially from L cells located mainly in the ileum. Both hormones prolong intestinal…”
Get full text
Journal Article -
15
The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection
Published in Gut (01-10-1998)“…Background—Medium chain C8–C10 triglycerides (MCTs) improve fat absorption in short bowel patients. Effects on overall energy absorption remain unknown…”
Get full text
Journal Article -
16
Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 : Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function
Published in Gastroenterology research and practice (01-01-2009)“…Background and aims. In a short-term study, Glucagon-like peptide 2 (GLP-2) has been shown to improve intestinal absorption in short bowel syndrome (SBS)…”
Get full text
Journal Article -
17
Clinical significance of GLP-2 in short-bowel syndrome
Published in The Journal of nutrition (01-11-2003)“…Although long-term parenteral nutrition is lifesaving in patients with intestinal failure, it is expensive, severely impairs the quality of life in the…”
Get more information
Journal Article -
18
Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection
Published in Gut (01-05-2003)“…Background and aims: Vitamin D deficiency is common in patients with small intestinal resection and may lead to secondary hypersecretion of parathyroid hormone…”
Get full text
Journal Article -
19
Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure
Published in Gut (01-10-1999)“…BACKGROUND Glucagon-like peptide 2 (GLP-2) is a growth factor for the intestinal epithelium in rodents and may affect intestinal transit. AIMS To study the…”
Get full text
Journal Article -
20
Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection
Published in Gut (01-12-1998)“…Background—H2 receptor blockers and proton pump inhibitors reduce intestinal output in patients with short bowel syndrome. Aims—To evaluate the effect of…”
Get full text
Journal Article